Results 141 to 150 of about 7,134 (210)

Phosphorylation of inner core heptose is a major determinant of bacterial surface lipopolysaccharide recognition by the innate immune protein hSP-D. [PDF]

J Biol Chem
Williams HM, Watson A, Madsen J, Clark HW, Hood DW, Oscarson S, Greenhough TJ, Shrive AK.   +7 more
europepmc   +1 more source

Role of intrarenal complement production in kidney transplantation. [PDF]

Clin Kidney J
Molinari P, Wadnerkar S, Ferrari KL, Castellano G, Chun N, Cravedi P.   +5 more
europepmc   +1 more source

Carbonic anhydrase 2-derived drug-responsive domain regulates membrane-bound cytokine expression and function in engineered T cells. [PDF]

Commun Biol
Inniss MC, Smith SG, Li DJ, Primack B, Sun D, Olinger GY, Sheahan KL, Ross T, Langley M, Young V, Alvarado A, Davoodi S, Geng J, Schebesta M, Ols ML, Tchaicha J, Ter Meulen J, Sethi DK.   +17 more
europepmc   +1 more source

Advances in Complement-Targeted Therapy for IgA Nephropathy. [PDF]

Kidney Dis (Basel)
Lu M, Li G.
europepmc   +1 more source

Differences in biomarker levels and proteomic survival prediction across two COVID-19 cohorts with distinct treatments. [PDF]

iScience
Hansen CB, Møller MEE, Pérez-Alós L, Israelsen SB, Drici L, Ottenheijm ME, Nielsen AB, Wewer Albrechtsen NJ, Benfield T, Garred P.   +9 more
europepmc   +1 more source

Do microenvironmental changes in degenerative disc disease reflect in systemic circulation? A proteomic investigation. [PDF]

Clin Proteomics
Nayagam SM, Palraj ND, Eswaran M, Selvaraj G, Rajendran S, Ramachandran K, Arunachalam D, Tangavel C, K S SA, Raveendran M, Rajasekaran S.   +10 more
europepmc   +1 more source

The Diabetes-Viral Respiratory Syndemic: Pathophysiological Insights and Precision Management: A Scoping Review. [PDF]

Medicina (Kaunas)
Mihai AM, Marc M, Lucaciu F, Sima A.
europepmc   +1 more source

Transcriptional Profiling of Abomasal Mucosa from Young Calves Experimentally Infected with <i>Ostertagia ostertagi</i>. [PDF]

Int J Mol Sci
Boschiero C, Beshah E, Bakshi M, Miramontes E, Hebert D, Thompson PC, Li CJ, Zhu X, Zarlenga D, Liu GE, Tuo W.   +10 more
europepmc   +1 more source

Effects of Empagliflozin in Type 2 Diabetes With and Without Chronic Kidney Disease and Nondiabetic Chronic Kidney Disease: Protocol for 3 Crossover Randomized Controlled Trials (SiRENA Project). [PDF]

JMIR Res Protoc
Nielsen SF, Duus CL, Buus NH, Bech JN, Mose FH.   +4 more
europepmc   +1 more source